Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00080184 · ClinicalTrials.gov registry record · Phase 1
Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00080184 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 40 participants.
The verdict
NCT00080184, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.
Interventions
- PROCEDURE Low Energy Neurofeedback System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00080184
The ClinicalTrials.gov registry entry for NCT00080184 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low Energy Neurofeedback System is the first listed.
NCT00080184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00080184 about?
NCT00080184 is a clinical study titled "Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia". The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.
What is the current status of trial NCT00080184?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2003-12. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00080184?
The interventions under investigation include: Low Energy Neurofeedback System (PROCEDURE).
Who is sponsoring clinical trial NCT00080184?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.